Below are current clinical trials.1 studies in Gastrointestinal stromal tumors (GISTs)
(open studies only).
Filter this list of studies by location, status and more.
Factors Contributing to Delay in Diagnosis of Bone/Soft Tissue Sarcoma
Study type: Observational What is this?
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
About this study
Information regarding the delay in diagnosis as well as the causes of the delay are lacking in the U.S. Specifically, we aim to identify patient factors and provider factors that contribute to delayed diagnosis of sarcoma.
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
Print study details
- Rochester, Minnesota: 15-000944
Sponsor Protocol Number: 15-000944
April 28, 2016
- AskMayoExpert. Gastrointestinal stromal tumor. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- Feldman M, et al. Gastrointestinal stromal tumors (GISTs). In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed April 15, 2016.
- Gastrointestinal stromal tumors treatment – Patient version (PDQ). National Cancer Institute. http://www.cancer.gov/types/soft-tissue-sarcoma/patient/gist-treatment-pdq. Accessed April 15, 2016.
- Soft tissue sarcoma. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed April 15, 2016.
Gastrointestinal stromal tumors (GISTs)